Keck School Of Medicine Of Usc | sciencenewsnet.in

Breaking News

Future Parents More Likely to Get RSV Vaccine When Pregnant if Aware That RSV Can Be a Serious Illness in Infants

Transforming Agriculture and Medicine: The Impact of Gene-Based Breeding (GBB)

ADDMAN Secures Qualification Project for CuNi Submarine Fittings with the US Navy

It’s easier now to treat opioid addiction with medication — but use has changed little

Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease

A new report from the American Lung Association shows nearly 40% of people across the U.S. are living in areas that are heavily polluted.

Five facilities at Argonne where climate solutions are front and center

For Immigrants to Canada, Risk of MS Increases with Proportion of Life Spent There

Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

Sweet potato quality analysis is enhanced with hyperspectral imaging and AI

25 Apr, 2024

Significantly less addictive opioid may slow progression of osteoarthritis while easing pain

July 13, 2020 sarah JonasResearch Results

A Keck Medicine of USC study reveals that kappa opioids, a significantly less addictive opioid, may preserve cartilage in joints and ease pain

Dr. Maurice O’Gorman to Speak on AAAS Webinar about Immune System Monitoring to Combat COVID-19

April 28, 2020 sarah JonasAnnouncement

Dr. O’Gorman, Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. During this webinar, Dr. O’Gorman will discuss early results from labs around the world that have begun measuring CD4 and CD8 T-cell levels in peripheral blood as potential biomarkers for the prognosis of patients with COVID-19.

Keck Medicine of USC announces launch of USC Epilepsy Care Consortium to serve epilepsy patients throughout Southern and Central California

November 19, 2019 sarah JonasAnnouncement

Keck Medicine of USC announces the launch of the USC Epilepsy Care Consortium, a unique partnership of six independent epilepsy centers serving patients in Los Angeles County, Orange County and the Central Valley.